The global Swab And Viral Transport Medium Market could reach about US$ 8.86 billion in 2023, according to FMI’s recent market analysis. By 2033, FMI also anticipated that the market could expand at a 5.8% CAGR and reach a value of US$ 15.60 billion.
During the COVID-19 pandemic, there has been a rise in demand for swabs and viral transport mediums. Companies have improved their manufacturing capacity to manufacture items suitable for viral collection, maintenance, and culture as a result of research institutions and labs stepping up their efforts to develop COVID-19 vaccines.
Request Sample Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-11195
Companies in the swab and viral transport medium business are producing inventive kits with vials, double-ended flocked swabs, medications, and other items that avoid bacterial or fungal contamination. They are concentrating on a better solution formulation to stop the growth of bacterial and fungal flora. The market is expanding owing to new viral transport medium solutions.
An additional element fueling the market expansion is the rise in the number of novel viruses that have the potential to infect humans and cause a variety of illnesses. According to an article in Nature from 2021, certain respiratory viruses are resurfacing in unexpected ways as pandemic limitations loosen. Infections with the respiratory syncytial virus (RSV), which accounts for 5% of all pediatric fatalities globally, began to rise in April 2021. As a result of the increased need for specimen collection kits and diagnosis, the prevalence of additional infectious illnesses is predicted to propel market expansion.
Manufacturers are creating viral transport mediums for influenza diagnostics as the flu season gets underway. Healthcare in western nations is extremely concerned about influenza-related morbidity and death. To provide swabs and viral transport mediums, manufacturers are expanding their research and development capabilities. Manufacturers are also starting to recognize the advantages of online pharmacies over hospitals and retail pharmacies. To increase their revenue sources, they are working with established e-Commerce companies.
Owing to its highly developed medical infrastructure and high frequency of infectious illnesses, North America is predicted to dominate the global market during the forecast period. During the pandemic, North America saw a spike in laboratory testing, which fueled the market expansion. The market is also growing significantly due to the existence of biopharma businesses, a large number of labs, and research studies on viral infection.
Ask An Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-11195
KEY TAKEAWAYS
- The market in the United Kingdom is anticipated to rise, exhibiting a CAGR of 5.9% through 2033.
- The United States is expected to develop at a 6.1% CAGR during the forecast period.
- With a CAGR of 4.0% over the forecast period, Canada is predicted to develop promptly in the market.
- In China, the market is expected to proliferate, registering a CAGR of 7.7% over the forecast period.
- Germany is estimated to grow decently registering a CAGR of 6.7% until 2033.
COMPETITIVE LANDSCAPE
Top players operating in the swab and viral transport medium market are McKesson Corporation, Cardinal Health Inc., Becton, Dickinson and Company, Thermo Fisher Scientific Inc., Quidel Corporation, COPAN Diagnostics Inc., VIRCELL S.L., Deltalab, Titan Biotech Ltd., Medical Wire & Equipment, and others.
These market players are always inventing and creating new products to suit the various requirements of diagnostic laboratories and research institutions. They are enhancing the design and components used in swabs to enhance their collection efficacy. They are also developing transport mediums that can hold viral specimens for extended periods without compromising their vitality. Additionally, to improve the stability and accuracy of diagnostic samples, they are also combining advanced technologies.
Request Customization@ https://www.futuremarketinsights.com/customization-available/rep-gb-11195
RECENT DEVELOPMENTS
- In June 2022, the start of long-distance drone deliveries in North Carolina was announced by Zipline and Cardinal Health.
- In May 2020, in several pharmacies across the United States, Health Mart® pharmacies announced that they would provide free COVID-19 test collection. Health Mart is dedicated to creating cutting-edge public and private collaborations as a member of the McKesson Corporation to assist address the COVID-19 epidemic.
Other Key Players Operating in the Swab and Viral Transport Market
- Thermo Fisher Scientific Inc.,
- Quidel Corporation,
- COPAN Diagnostics Inc.,
- VIRCELL S.L., Deltalab,
- Titan Biotech Ltd.,
- Medical Wire & Equipment
Swab and Viral Transport Medium Market by Category
By Product:
- Viral Transport Medium
- Tissue Culture Medium
- Glycerol Transport Medium
- Virus Swabs
- Nasopharyngeal Swabs
- Deep Nasal Swabs
- Combined Nasal & Throat Swabs
- Culture Swabs
- Vaginal Swabs
By Application:
- Influenza
- Respiratory syncytial virus
- Mumps Virus
- Adenovirus
- Rhinovirus
- Herpes Simplex Virus
- Varicella-Zoster Virus
- Other Indication
By End User:
- Hospitals & ASCs
- Specialty Clinics
- Diagnostic Laboratories
- Others
Top Related Reports:
Enteral Feeding Devices Market
About Future Market Insights (FMI)
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports